»ï¼º¼¿ïº´¿ø Á¦18ȸ »ï¼ºÈ²¹Ý½ÉÆ÷Áö¿ò : 2018-10-13±³À°ÀÏÀÚ : 2018-10-13
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
Á¦18ȸ »ï¼ºÈ²¹Ý½ÉÆ÷Áö¿ò ÁÖÃÖ±â°ü : »ï¼º¼¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú
´ã´çÀÚ : Ç¥¼ºÈñ
¿¬¶ôó : 02-3410-3568
À̸ÞÀÏ :
sunghee.pyo@samsung.com ±³À°Á¾·ù : ¾È°ú±âŸ
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ïºñ (Àü°øÀÇ-4¸¸¿ø, Àü¹®ÀÇ-6¸¸¿ø) ÇöÀåµî·Ïºñ (Àü°øÀÇ-6¸¸¿ø, Àü¹®ÀÇ-8¸¸¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 09:00~09:10 Subclinical neovascularization in nonexudative AMD ¹Ú¿µÈÆ(°¡Å縯´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 09:10~09:20 OCTA findings and treatment response in exudative AMD ¹è°ÇÈ£(¼º±Õ°ü´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 09:20~09:30 Automated segmentation of lesions in AMD ±èÇüÂù(°Ç±¹´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 09:30~09:40 OCTA biomarkers of functional outcome predictors in diabetic retinopathy ±è¼º¿ì(°í·Á´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 09:40~09:50 Changes in FAZ in various retinal conditions ¿ÀÀç·É(°í·Á´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 09:50~10:00 Potential role of OCT for neurodegenerative disease ¾ÈÁöÀ±(¼¿ï´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 10:00~10:10 New and emerging therapies for neovascular AMD ¹Ú¿îö(¼¿ï´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 10:10~10:20 Treatment options for submacular hemorrhage ±èÀçÈÖ(±è¾È°úº´¿ø)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 10:20~10:30 Non-typical AMD À̼ºÃ¶(¿¬¼¼´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 10:30~10:40 Updates on intraocular sustained drug delivery ¼Û¼öÁ¤(¼º±Õ°ü´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 10:40~10:50 Lessons learned from DRCR.net protocols ¹Ú¼ºÇ¥(ÇѸ²´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 10:50~11:00 Subthreshold laser therapies Á¶ÈñÀ±(ÇѾç´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 11:30~11:40 Surgical options for large macular holes °¼¼¿õ(¼º±Õ°ü´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 11:40~11:50 Surgical outcomes of lamellar macular hole ¼ÕÁØÈ«(Çѱæ¾È°úº´¿ø)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 11:50~12:00 When and how to treat epiretinal membrane ³²µ¿Èç(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 12:00~12:10 When and how to treat myopic traction maculopathy ÀÌ¿ø±â(°¡Å縯´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 12:10~12:20 Treatment of optic pit maculopathy º¯¼®È£(¿¬¼¼´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 13:30~13:40 PDR surgery: cutter only dissection, scissors vs cutter, viscodissection ±èÁß°ï(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 13:40~13:50 Pre- and intra-operative anti-VEGF for diabetic vitrectomy ¹ÚÅ°ü(¼øõÇâ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 13:50~14:00 ERM / ILM removal in DR À¯Çü°ï(¼¿ï´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 14:00~14:10 Surgical strategies for PVR ÁøÈñ½Â(ÀÎÇÏ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 14:10~14:20 Retinal detachment after open globe injury Á¶¿µÁØ(Ãæ³²´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 14:20~14:30 3D Digitally Assisted Vitrectomy ¹Ú±ÔÇü(¼¿ï´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 15:00~15:10 Surgery for pediatric retinal detachment ÀÌÁÖ¿ë(¿ï»ê´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 15:10~15:20 Combined lensectomy and vitrectomy for pediatric retinal diseases including ROP ±è»óÁø(¼º±Õ°ü´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 15:20~15:30 Diagnostic vitrectomy: surgical considerations ±èÇö¿õ(ÀÎÁ¦´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 15:30~15:40 Surgery for exudative retinal detachment: when and how? ½ÅÀçÇÊ(°æºÏ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 15:40~15:50 Various techniques in management of dropped nucleus À̽¿ì(µ¿±¹´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 15:50~16:00 My tips in the management of dislocated IOL-I ÃÖ°æ½Ä(ÃáõÇâ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ´ë°´ç 16:00~16:10 My tips in the management of dislocated IOL-II À±Èñ¼º(¼º¸ð¾È°úº´¿ø)